The cost effectiveness of screening newborns for congenital adrenal hyperplasia.

Public health genomics

Volumn 12, Issue 2, 2009, Pages 67-72

  Yoo, B K ^a   Grosse, S D ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONGENITAL ADRENAL HYPERPLASIA; COST BENEFIT ANALYSIS; ECONOMICS; HUMAN; INCIDENCE; NEWBORN; NEWBORN SCREENING; OUTCOME ASSESSMENT; PREDICTION AND FORECASTING; PROBABILITY; PUBLIC HEALTH; QUALITY ADJUSTED LIFE YEAR; SENSITIVITY AND SPECIFICITY; UNITED STATES;

ADRENAL HYPERPLASIA, CONGENITAL; COST-BENEFIT ANALYSIS; HUMANS; INCIDENCE; INFANT, NEWBORN; NEONATAL SCREENING; OUTCOME ASSESSMENT (HEALTH CARE); PREDICTIVE VALUE OF TESTS; PROBABILITY; PUBLIC HEALTH; QUALITY-ADJUSTED LIFE YEARS; SENSITIVITY AND SPECIFICITY; UNITED STATES;

EID: 58949100737     PISSN: None     EISSN: 16628063     Source Type: Journal    
DOI: 10.1159/000156115     Document Type: Article

References (0)